UNRESECTABLE PANCREATIC ADENOCARCINOMA
Clinical trials for UNRESECTABLE PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough pancreatic cancer: targeted drug combo under study
Disease control Recruiting nowThis study tests whether adding a targeted drug called panitumumab to standard chemotherapy helps people with a specific type of advanced pancreatic cancer (KRAS wild-type) live longer. About 94 adults whose cancer has spread or can't be removed will be randomly assigned to get c…
Matched conditions: UNRESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Can a statin boost chemo for pancreatic cancer?
Disease control Recruiting nowThis early-phase trial tests adding the cholesterol-lowering drug pitavastatin to standard chemotherapy (gemcitabine and nab-paclitaxel) as maintenance therapy for people with advanced pancreatic cancer that cannot be removed by surgery. About 18 adults whose disease is stable af…
Matched conditions: UNRESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug TR-002 enters human testing for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial is testing a new chemotherapy drug called TR-002 in about 52 people with advanced solid tumors, including pancreatic cancer that has stopped responding to standard treatments. The main goals are to find a safe dose and check for side effects. Researchers wi…
Matched conditions: UNRESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Scientists hunt for hidden subtypes of cancer wasting
Knowledge-focused Recruiting nowThis study is observing 800 people with advanced lung, colorectal, or pancreatic cancer to understand why some lose weight and muscle (cachexia). Researchers hope to find distinct subtypes of cachexia, which could lead to better, more personalized treatments in the future. Partic…
Matched conditions: UNRESECTABLE PANCREATIC ADENOCARCINOMA
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC